Starting 1 January 2017, Sanofi Pasteur and MSD will end their vaccines joint venture in Europe, to independently manage their product portfolios and pursue their own vaccine strategies in Europe.
Please note Sanofi Pasteur MSD’s websites are now closed.
For more information about Sanofi Pasteur or MSD vaccines, please visit their respective websites:
|SANOFI PASTEUR VACCINES|
|Inactivated Influenza Vaccine (split virion) BP|
|Quadrivalent Influenza Vaccine (split virion, inactivated)|
|Pneumococcal Polysaccharide Vaccine|
|VAQTA® (Adult and Paediatric)|